3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one , 97% , 55314-16-4
CAS NO.:55314-16-4
Empirical Formula: C10H12N2O
Molecular Weight: 176.22
MDL number: MFCD00115180
EINECS: 1533716-785-6
Pack Size | Price | Stock | Quantity |
1G | RMB23.20 | In Stock |
|
250MG | RMB23.20 | In Stock |
|
5G | RMB28.00 | In Stock |
|
25G | RMB93.60 | In Stock |
|
100G | RMB375.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 86-88 |
Boiling point: | 281.4±36.0 °C(Predicted) |
Density | 1.070±0.06 g/cm3(Predicted) |
vapor pressure | 0.049Pa at 20℃ |
storage temp. | Inert atmosphere,Room Temperature |
solubility | Soluble in chloroform and dichloromethane. |
pka | 6.19±0.70(Predicted) |
form | powder to crystal |
color | Light yellow to Brown |
InChIKey | MZLRFUCMBQWLNV-FNORWQNLSA-N |
LogP | 0.26 at 20℃ and pH7.2 |
Surface tension | 71.8mN/m at 1.008g/L and 20℃ |
Description and Uses
1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one can be used in the synthesis of imatinib and nilotinib (AMN107), a compound currently in multiple Phase II/III clinical trials for chronic granulocytic leukaemia. Imatinib, on the other hand, is a cancer growth blocker known as a tyrosine kinase inhibitor (TKI), which is used to treat a wide range of leukaemias, myelodysplastic/myeloproliferative disorders, systemic mastocytosis, eosinophilia syndromes, raised dermal fibrosarcoma and gastrointestinal mesenchymal tumours.
3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one is used ads pharmaceutical intermediate, an imatinib intermediate.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P280a-P304+P340-P305+P351+P338-P405-P501a-P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313 |
Hazard Codes | Xi,Xn |
Risk Statements | 22-36/37/38 |
Safety Statements | 26-36/37/39 |
HazardClass | IRRITANT |
HS Code | 29333990 |